Board / shareholder meeting outcomeFiled on BSE ·
Aptus Pharma Ltd issues corrigendum to AGM notice and announces e-voting details
Aptus Pharma Ltd · Pharmaceuticals & Biotechnology
What the filing says
- AGM to be held on 14th September 2026 via VC/OAVM, with corrigendum issued on 7th September 2026
- Correction relates to proposed preferential issue of 16,02,870 equity shares under Item No. 3
- E-voting open from 11th September 2026 (9:00 a.m.) to 13th September 2026 (5:00 p.m.) via CDSL
Original filing
CORRIGENDUM / ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other board / shareholder meeting outcome filings this fortnight
- Board / shareholder meeting outcomeTitan Biotech LtdTitan Biotech Limited holds 34th Annual General Meeting via video conferencing on Sept 29, 2026
- Board / shareholder meeting outcomeNLC India LtdNLC India Limited announces FY 2025-26 results and 70th AGM outcomes
- Board / shareholder meeting outcomeGrand Oak Canyons Distillery LtdGrand Oak Canyons Distillery Ltd announces voting results of 41st AGM held on 26 Sept 2026
- Board / shareholder meeting outcomeVasa DenticityVasa Denticity Limited holds 10th AGM via video conferencing on Sept 29, 2026
- Board / shareholder meeting outcomeManali Petrochemicals LtdManali Petrochemicals Limited holds 40th AGM, approves dividend and re-election
- Board / shareholder meeting outcomePatil Automation LtdPatil Automation Limited issues corrigendum to EGM notice revising allotment details
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.